What are the chances of survival in Gall Bladder Carcinoma if the GB has diffused into liver? Help required?

Question

The patient is not having jaundice, has completed her two cycles of chemotherapy with Gemcitebine(1.4) and Capecitabine (2500 mg/day), is able to eat properly and healthy bowel movements. No vomiting but feels nausea once in a while. Fever comes for 5-6 hours a day and the max temperature is 102 F. Pain in the back and sides of ribs. Feels better for 24 hours after taking a single dose of Diclofenac-75 mg (brand name- Voveron). Not bed ridden, but becoming weak. Still doing her half hour walks twice a day. Voice has become too weak to be heard over phone. Radiotherapy and surgery scheduled in the coming week. Please help.

Answer 1

Search for answers by looking outside of the medical field, in the area of alternative medicine. There are hundreds of methods to heal the body, and drugs only suppress the issue (not heal it). Most disease issues are internal because the blood carries toxins that accumulate in the body. The system needs to be cleansed (colon and liver especially), and given nutrition.

Cleansing the body is a method Ive seen done many times with success and it doesn't matter how old you are. We must remove toxins. One strategy is detoxifying with herbs, water, and juice fasting. One must educate oneself.

"The Cure for All Cancers"
"A Cancer Therapy"
"Oxygen Therapies"
"Hydrogen Peroxide--Medical Miracle"
"The Natural Cure for Cancer--Germanium"
"Killing Cancer"
"Natural Cures 'They' Don't Want You to Know About"

There are many other good books about surviving this disease, and you should know about this option, even if you choose to go the traditional route with it's abysmal prognosis. Best of luck.

And watch this--you'll be glad you did.
http://www.altcancer.com/video/hoxsey_ds...

Answer 2

INTRODUCTION: There are various options for the treatment of gallbladder carcinoma; however, only radical resection offers a chance for prolonged survival. METHODS: The aim of this study was to analyze retrospectively patients suffering from gallbladder carcinoma in a central hospital in Austria. From 1986 to 1999, 77 patients were treated in this surgical department. The median age of the patients was 71.3 years. RESULTS: In 28 patients the cancer was resected and 22 persons underwent palliative surgery. An explorative laparotomy was performed in 16 patients. Eleven patients had no surgical therapy, 10 persons received gemcitabine or a combination chemotherapy regimen consisting of leucoverin, 5-fluorouracil and mitomycin C. The median survival of patients without chemotherapy following radical resection (n = 15) was 10.7 months (one patient with metastatic cancer was excluded) and for patients with tumor remaining margins (n = 8) 3.2 months (P = 0.023). Without chemotherapy the median patient survival following palliative resection (n = 17) and explorative laparotomy (n = 15) was 1.5 months and 2.1 months. The median survival without surgical therapy was 1.6 months. Chemotherapy was administered to four of the resected patients (median survival 16.5 months), in five patients following palliative surgery and in one patient after explorative laparotomy (median survival 4.3 months) (P = 0.034). In a multivariate analysis, tumor resection (P = 0.034) and tumor-free resection margins (P = 0.025) proved to be the most important determinants for patient survival. CONCLUSION: Tumor resection is the most important factor for a prolonged patient survival. Following radical resection in an early tumor stage and combining this approach with an established chemotherapy, patient survival could be increased significantly.

Answer 3

Hi,There is a nutritional product that's clinically proven to trigger an immune response in the body creating a system of defense against viral,bacterial and neoplastic(abnormal tissue growth) invaders in the body.It has also been shown to increase the effectiveness of antibiotics and antiviral medications.It is called Beta1,3D-glucan,more details at www.dna911.info Also information on latest cancer research with Beta Glucan.